Search results
Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant
Benzinga via Yahoo Finance UK· 1 day agoFrench drugmaker Sanofi is poised to commit between 1.3 billion euros and 1.5 billion euros ($1.4...
Election night is long, but I shall be on form at the New Statesman party
The New Statesman· 5 hours agoIncidentally, my favourite headline of the campaign is now over a month old, but it actually gets...
The secret history of strawberries
The New Statesman· 5 hours agoThey are the perfect summer fruit – and the kitchen can’t improve on perfection.
Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
Zacks via Yahoo Finance UK· 4 days agoImage Source: Zacks Investment Research In the last five trading sessions, Lilly rose the most...
Netflix fans go wild as mid-2000s favorite lands on streaming platform
Daily Mail· 21 hours agoThe cast of the series includes Jorge Garcia, Josh Holloway, Yunjin Kim, Matthew Fox, Evangeline ...
HIMS Stock Tumbles: Here's Why It's a Buy Right Now
Zacks via Yahoo Finance UK· 4 days agoThe market has been dominated by pharmaceutical giants Eli Lilly (LLY) and Novo Nordisk (NVO). However, I see significant opportunities for less mature...
Sunak’s honours list faces a Starmer peer review
The New Statesman· 5 hours agoYour weekly dose of gossip from the campaign trail.
Oldenburg Academy scholarship and awards information
Greensburg Daily News, Ind.· 20 hours agoJul. 1—Oldenburg Academy is proud to announce the accomplishments of its graduating class of 2024. The 37 seniors earned 121 college scholarships, for a combined total of $7.5 million. The range ...
Will the Tories ever recover from this defeat?
The New Statesman· 9 hours agoThis was an election campaign that – from a Conservative perspective – was all about damage limitation. Perhaps left-wing electors might get their sense...
2 PRIMECAP Funds to Look Into as Vanguard Reopens Them
Zacks via Yahoo Finance UK· 6 days agoVPCCX can invest in stocks across all sectors and market caps. Joel P. Fried has been one of the...